NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and certain of the Company’s senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc. Investors have until December 16, 2024 to ask the Court to be appointed to lead the case. The c ...

Acadia Healthcare (ACHC) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.90 per share. This compares to earnings of $0.91 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 1.11%. A quarter ago, it was expected that this provider of inpatient behavioral health care services would post earnings of $0.88 per share when it actually produced earnings of $0.91, delivering a surprise of ...

财务业绩 - 第三季度收入达8.156亿美元，同比增长8.7%[2] - 第三季度调整后EBITDA为1.94亿美元，同比增长7.7%[27] - 前三季度收入为23.77亿美元，同比增长9.7%[27] - 前三季度调整后EBITDA为5.56亿美元，同比增长9.8%[27] 盈利能力 - 归属于Acadia的净收益为6810万美元，每股摊薄收益0.74美元[2] - 经调整的归属于Acadia的收益为8410万美元，每股摊薄收益0.91美元[2] - 第三季度调整后每股收益为0.91美元，同比增长-4.2%[28] - 前三季度调整后每股收益为2.66美元，同比增长1.5%[28] 运营数据 - 同店收入增长8.6%，其中每日患者收入增长3.6%，患者日增长4.7%[2] - 同店经调整的EBITDA利润率增加100个基点至29.7%[2] - 第三季度同店收入增长8.6%，同店患者日增长4.7%[21] - 第三季度同店入院人次增长2.0%，平均住院时间增长2.7%[21] - 第三季度同店收入每患者日为1,002美元，同比增长3.6%[21] - 前三季度同店收入增长8.7%，同店患者日增长3.2%[21] - 前三季度同店入院人次增长0.3%，平均住院时间增长2.8%[21] - 前三季度同店收入每患者日为1,001美元，同比增长5.3%[21] 财务状况 - 公司现金及现金等价物为4.32亿美元[33] - 公司净负债率为3.1倍[33] 未来展望 - 公司在第三季度新增15张床位和5家新的CTC中心，目前共有164家CTC中心[4] - 公司预计全年新增超过400张床位，其中第四季度新增超过300张[5,6] - 公司预计全年收入为31.5亿至31.65亿美元，经调整EBITDA为7.25亿至7.35亿美元，经调整每股收益为3.35美元至3.45美元[11]

财务业绩 - 公司在2024年9个月内实现收入增长8.7%，达到23.79亿美元[66] - 同店收入增长8.7%，患者日增长3.2%，入院人次增长0.3%[67] - 同店收入每患者日增长5.3%，调整后EBITDA利润率提升50个基点[67] - 收入增加8.7%至8.156亿美元，同店收入增加8.6%[69] - 工资、薪酬和福利费用增加8.6%至4.281亿美元，占收入51.3%[69] - 专业费用占收入5.9%，同店专业费用占收入5.3%[69] - 供应费用占收入3.6%，同店供应费用占收入3.6%[69] - 其他经营费用占收入13.8%，同店其他经营费用占收入12.9%[69] - 利息费用增加至2990万美元，主要由于2024年信贷融资增加[69] - 所得税费用为2720万美元，有效税率为27.6%[71] - 收入增加8.9%至23.797亿美元，同店收入增加8.7%[72] - 工资、薪酬和福利费用增加8.0%至12.654亿美元，占收入52.0%[72] - 专业费用占收入6.0%，同店专业费用占收入5.3%[74] - 2024年前三季度收入为23.797亿美元，同比增长9.0%[80] - 2024年前三季度经营活动产生的现金流为1.3亿美元，2023年同期为34.6亿美元[80] 业务拓展 - 公司在38个州和波多黎各地区共运营260家行为健康设施，约11,300张床位[63] - 公司在2024年9个月内新增275张床位，其中67张来自现有设施扩建，208张来自4家新开设的全资设施[63] - 公司计划通过现有设施扩张、合资、新建、收购等多种方式继续扩大业务规模[65] 管理团队 - 公司是美国领先的行为健康服务纯粹上市公司，拥有丰富的行业经验管理团队[65] 应对措施 - 公司正积极采取多种策略以应对当前紧张的劳动力市场，包括确保各市场有足够的员工满足需求[66] - 公司同店收入增长主要得益于患者日增长和每患者日收入增长[67] - 公司调整后EBITDA利润率提升主要得益于收入增长和成本控制[68] 财务状况 - 2024年9月30日应收账款账龄情况中，当前账龄占64.0%，30-90天账龄占12.4%，90-150天账龄占6.8%，150天以上账龄占16.8%[79] - 2024年前三季度资本性支出为4.869亿美元，其中维护性支出7.13亿美元，扩张性支出4.156亿美元[80] - 2024年前三季度筹资活动产生的现金流为5.022亿美元，主要包括3.5亿美元长期债务借款、2.1亿美元银行贷款借款等[80,81] - 2024年9月30日公司可用现金及现金等价物为8.21亿美元，其中约5.9亿美元由海外子公司持有[81] - 2024年1月公司支付4亿美元和解费用以解决Desert Hills诉讼案[82] - 2023年3月公司修订信贷协议将LIBOR替换为Adjusted Term SOFR作为借款利率基准[83] - 2024年1月公司新增3.5亿美元增量定期贷款[83,84,85] - 2024年9月30日公司信贷协议中的财务指标均符合要求[85] - 公司发行了4.5亿美元5.500%优先票据和4.75亿美元5.000%优先票据[86] - 优先票据的契约包含限制公司及其受限子公司的条款[86] - 优先票据由公司的所有担保子公司提供全面无条件的连带担保[86] - 公司可以选择在特定日期和金额赎回优先票据[86] - 截至2024年9月30日和2023年12月31日,公司担保子公司的资产负债表信息[87][88] - 2024年前9个月,公司担保子公司的经营业绩信息[89] - 截至2024年9月30日,公司的合同义务包括长期债务、经营租赁和融资租赁[90] - 公司的利率风险敏感性分析显示,利率上升1%将使税前收益减少约960万美元[92]

RADNOR, Pa., Oct. 30, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare") (NASDAQ: ACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 18, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 16, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 29, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Acadia Healthcare Company, Inc. ("Acadia Healthcare" or the "Company") (NASDAQ: ACHC) investors of a class action representing investors that bought securities between February 28, 2020 and September 26, 2024, inclusive (the "Class Period"). Acadia Healthcare investors have until December 16, 2024 to file a lead plaintiff motion. Investors are ...

SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all investors and entities that purchased or otherwise acquired Acadia Healthcare Company (NASDAQ: ACHC) securities between February 28, 2020 and September 26, 2024. Acadia is a leading provider of behavioral healthcare services across the United States. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is ...

NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) between February 28, 2020 and October 18, 2024, both dates inclusive (the “Class Period”) of the important December 16, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Acadia Healthcare securities during the Class Period you may be entitled to compensation without ...

NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Acadia Healthcare Company, Inc. (NASDAQ:ACHC) and certain of the Company’s senior executives. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc. Investors have until December 16, 2024 to ask the Court to be appointed to lead the case. The ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 28, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Acadia Healthcare Company, Inc. ("Acadia Healthcare" or the "Company") (NASDAQ: ACHC) investors of a class action representing investors that bought securities between February 28, 2020 and October 18, 2024, inclusive (the "Class Period"). Acadia Healthcare investors have until December 16, 2024 to file a lead plaintiff motion. Investors are en ...